0000318306-16-000051.txt : 20161215
0000318306-16-000051.hdr.sgml : 20161215
20161215194820
ACCESSION NUMBER: 0000318306-16-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161213
FILED AS OF DATE: 20161215
DATE AS OF CHANGE: 20161215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3333 LEE PARKWAY
STREET 2: SUITE 600
CITY: DALLAS
STATE: TX
ZIP: 75219
BUSINESS PHONE: 2149055100
MAIL ADDRESS:
STREET 1: 3333 LEE PARKWAY
STREET 2: SUITE 600
CITY: DALLAS
STATE: TX
ZIP: 75219
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jeffrey B Davis
CENTRAL INDEX KEY: 0001349083
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 162054826
BUSINESS ADDRESS:
STREET 1: C/O SCO FINANCIAL GROUP LLC
STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-554-4158
MAIL ADDRESS:
STREET 1: C/O SCO FINANCIAL GROUP LLC
STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-12-13
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001349083
Jeffrey B Davis
3333 LEE PARKWAY SUITE 600
DALLAS
TX
75219
1
1
0
0
Chief Operating Officer
Stock option (right to buy)
4.45
2016-12-13
4
A
0
37500
0
A
2017-12-13
2026-12-13
Common stock
37500
37500
D
Stock option (right to buy)
4.45
2016-12-13
4
A
0
112500
0
A
2018-01-13
2026-12-13
Common stock
112500
150000
D
100% accelerated vesting on change of control.
After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date.
/s/ Jeffrey B. Davis
2016-12-15